Antiviral Activity of <i>Sterculia Quadrifida</i> R.Br Extract Against Dengue Serotype 2  Virus

Rr. Listyawati Nurina; Christina O. Lada; Rahel R. Woda; Prisca Pakan; Muhajirin Dean

doi:10.26538/tjnpr/v8i2.3

Authors

Rr. Listyawati Nurina Faculty of Medicine and Veterinary Science, Universitas Nusa Cendana, Indonesia
Christina O. Lada Faculty of Medicine and Veterinary Science, Universitas Nusa Cendana, Indonesia
Rahel R. Woda Faculty of Medicine and Veterinary Science, Universitas Nusa Cendana, Indonesia
Prisca Pakan Faculty of Medicine and Veterinary Science, Universitas Nusa Cendana, Indonesia
Muhajirin Dean Faculty of Medicine and Veterinary Science, Universitas Nusa Cendana, Indonesia

DOI:

https://doi.org/10.26538/tjnpr/v8i2.3

Keywords:

Dengue, antiviral, DENV-2, Flaviviridae, Sterculia

Abstract

There are four serotypes of dengue viruses (DENV1, 2, 3 and 4). Dengue is typically transmitted in a cycle involving humans and mosquito vectors. There has been a significant increase in the prevalence of dengue virus worldwide in recent decades. At present, there is no specific drug available to control the infection, and the most effective preventive measures are the control of the mosquito population. The objective of this study was to assess the antiviral properties of Sterculia quadrifida ethanol extract against dengue infection. The stem bark of Sterculia quadrifida R.Br was extracted using three different solvents: n-hexane, water, and 70% ethanol.
Dengue serotype 2 (DENV-2) virus was propagated in C6/36 cells. MTT reagents were used to perform cytotoxicity tests, and the antiviral activity of the extract was evaluated in Vero cells. The result of the cytotoxicity test showed that the extracts of Sterculia quadrifida caused the inhibition of DENV-2 with inhibitory potential of 19.156 μmg/mL, 3.592 μmg/ml, and 6.028 μmg/ml at concentrations of 36.296 μmg/mL, >200 μmg/mL, and 99.743 μmg/mL, for n-hexane, water, and 70% ethanol, respectively. The cytotoxicity of Sterculia quadrifida suggests it might be a valuable source of antiviral agents.

References

Wang WH, Urbina AN, Lin CY, Yang ZS, Assavalapsakul W, Thitithanyanont A, Lu PL, Chen YH, Wand SF. Targets and strategies for vaccine development against dengue viruses. Biomed and Pharm. 2021: 144, 112304.

Alagarasu K, Patil JA, Kakade MB, More AM, Yogesh B, Newase P, Jadhav SM, Parashar D, Kaur H, Gupta N, Vijay N, Narayan J, Shah PS. Serotype and genotype diversity of dengue viruses circulating in India: a multi-centre retrospective study involving the Virus Research Diagnostic Laboratory Network in 2018. Inter J of Infect Dis. 2021:111, 242-252.

Alfsnes K, Eldholm V, Gaunt MW, de Lamballerie X, Gould EA, Pettersson JHO. Tracing and tracking the emergence, epidemiology and dispersal of dengue virus to Africa during the 20th century. One Health. 2021:13, 100337.

Wahab NZA, Ibrahim N, Kamarudin MKA, Lananan F,Juahir H, Ghazali A, Yusra AFI. Cytotoxicity and antiviral activity of Annona muricata aqueous leaves extract against dengue virus type 2. J of Fund and App Sci. 2018:10(1S), 580-589.

Jain J, Kumar A, Narayanan V, Ramaswamy RS, Sathiyarajeswaran P, Devi MS, Kannan M, Sunil S. Antiviral activity of ethanolic extract of Nilavembu Kudineer against dengue and chikungunya virus through in vitro evaluation. J of Ayu and int med. 2020:11(3), 329-335.

Kotaki T, Yamanaka A, Mulyatno KC, Churrotin S, Sucipto TH, Labiqah A, Ahwanah NLF, Soegijanto S, Kameoka M, Konish E. Divergence of the dengue virus type 2 Cosmopolitan genotype associated with two predominant serotype shifts between 1 and 2 in Surabaya, Indonesia, 2008–2014. Infe, Gen and Evo. 2016:37, 88-93.

Sucipto TH, Churrotin S, Setyawati H, Martak F, Mulyatno KC, Amarullah IH, Kotaki T, Kameoka M, Yotopranoto S, Soegijanto S. New copper (II)-imidazole derivative effectively inhibits replication of DENV-2 in Vero cell. Afri J of Infec Dis. 2018:12(1S), 116-119.

Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, AbuBakar S. Novel antiviral activity of baicalein against dengue virus. BMC Compl and Alt Med. 2012:12(1), 1-9.

Ansori ANM, Fadholly A, Proboningrat A, Antonius Y, Hayaza S, Susilo RJK, Inayatillah B, Sibero MT, Naw SW, Posa GAV, Sucipto TH, Soegijanto, S. Novel antiviral investigation of Annona squamosa Leaf extract against the Dengue Virus Type-2: In vitro study. Pharm J, 2021: 13(2).

Perera N, Brun J, Alonzi DS, Tyrrell BE, Miller JL., Zitzmann N. Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells. Anti Res. 2022:199, 105269.

Sinha M, Chakraborty U, Kool A, Chakravarti M, Das S, Ghosh S, Thakur L, Khuranna A, Nayak D, Basu B, Kar S, Ray R, Das S. In-vitro antiviral action of Eupatorium perfoliatum against dengue virus infection: Modulation of mTOR signaling and autophagy. J Ethnopharmacol. 2022:282, 114627.

Khazali AS, Rashid NN, Fung SY, Yusof R. Lignosus rhinocerus TM02® sclerotia extract inhibits dengue virus replication and Infection. J of Herb Med. 2021:30, 1005